Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools
Log in
Sections
You are here: Home Members Pilar Blancafort
Pilar Blancafort

Pilar Blancafort

  • PhD
  • Molecular Therapeutics
  • Breast Cancer

  • Assistant Professor
  • UNC-Chapel Hill
  • pilarb@med.unc.edu
  • 919-966-1615
  • 102A Mary Ellen Jones Building Chapel Hill, NC 27599-7365

Area of Interest

The development of invasive and metastatic behavior during cancer progression is a dynamic process thought to require the concerted action of multiple genes and cellular functions, including cytoskeleton remodeling, acquisition of migratory phenotypes, ability to invade the tumor-surrounding tissues, and survival of disseminated tumor cells. The genetic cascades and transcriptional programs cooperatively required for the malignant progression of tumors are largely unknown. We have developed a novel strategy for the identification and regulation of genes that cooperate during tumor progression. This methodology is based on the screening of large libraries of ATFs made of sequence-specific zinc finger (ZF) domains. In one of our projects, our objective is to apply ATF methodology to identify and regulate genes promoting carcinoma cell invasion and metastasis. Our primary goal is to identify molecular markers of cancer cell invasion that could be used as markers or early detectors of disease progression. We hypothesize that 1) some selected ATFs will be able to regulate complex phenotypes, such as cancer cell invasion and metastatic potential and 2) the selected ATFs can be used to identify markers of cancer disease progression.